UNIGE document Scientific Article
previous document  unige:99170  next document
add to browser collection

La maladie d’Erdheim Chester : un diagnostic différentiel de fibrose rétropéritonéale

Published in Revue médicale suisse. 2017, vol. 13, no. 557, p. 743-747
Abstract Erdheim-Chester disease is a rare multisystemic non-Langerhans histiocytosis with about 500 reported cases. Typical features include retroperitoneal and perirenal fibrosis (hairy kidney), periaortitis with a coated aorta, osteosclerosis of the lower limbs, and sometimes exophthalmia or diabetes insipidus. Histology is the cornerstone for diagnosis showing an infiltrate with foamy histiocytes and occasional multinucleated giant cells (Touton cells). There is no standard treatment regimen, current options include corticosteroids, interferon alpha, systemic chemotherapy, and radiation therapy ; however, a better understanding of the pathophysiological mechanisms has allowed the emergence of novel targeted treatments such as vemurafenib, imatinib, and anakinra.
PMID: 28722363
Full text
Article (Published version) (2.2 MB) - public document Free access
Research group Groupe Seebach Jorg Dieter (transplantation et immunologie) (856)
(ISO format)
ANDRE, Raphaël, SEEBACH, Jorg Dieter. La maladie d’Erdheim Chester : un diagnostic différentiel de fibrose rétropéritonéale. In: Revue médicale suisse, 2017, vol. 13, n° 557, p. 743-747. https://archive-ouverte.unige.ch/unige:99170

91 hits



Deposited on : 2017-11-17

Export document
Format :
Citation style :